A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV
Trial details
- Registry ID
- NCT05904470
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as AT-527
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCVNCT05904470 | AVIR | Phase 2 | Completed | 2024-12-09Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |